Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis

@ChrisJohnsonMD @NateWeymouth @KitemanArgues @swedishchf @JRJHealey @Gousa881 @Monstercoyliar @ghoppe @_mamadeb @irishman7771 @VersaceJedi @mcfunny @BurgerLab12 @KayVonPaul @JaiKanta22 @markmcdougall13 @Chris_F_Carson @numbers_truth @Nycweatherrepor @Doubl

@Goss30Goss @GeraldoRivera @realDonaldTrump https://t.co/VkJ12NNZC2

@ScottAdamsSays https://t.co/VkJ12NNZC2. Surfactant therapy. My guess is researchers are looking back into the efficacy of this treatment injected into the breathing tube for Respiratory Distress Syndrome to also introduce agents targeted to the virus

Addition of #surfactant improves oxygenation in patients with #ARDS So far does not improve mortality But maybe in combination with other drugs or cells it may ? https://t.co/EGthzQ3V27